Brief Articles Open Access
Copyright ©2009 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Feb 28, 2009; 15(8): 973-977
Published online Feb 28, 2009. doi: 10.3748/wjg.15.973
Protective effects of electroacupuncture on acetylsalicylic acid-induced acute gastritis in rats
Hye Suk Hwang, Kyung-Ju Han, Yeon Hee Ryu, Eun Jin Yang, Yoo Sung Kim, Sang Yong Jeong, Young-Seop Lee, Myeong Soo Lee, Sun-Mi Choi, Department of Medical Research, Korea Institute of Oriental Medicine, Daejeon 305-811, South Korea
Sung Tae Koo, Division of Meridian and Structural Medicine, School of Oriental Medicine, Pusan National University, Pusan 609-735, South Korea
Author contributions: Hwang HS, Han KJ contributed equally to this work; Koo ST, Choi SM designed the research; Hwang HS, Han KJ, Kim YS, Jeong SY, Lee YS performed the research; Han KJ, Hwang HS, Ryu YH, Yang EJ, Lee MS analyzed the data and wrote the paper.
Correspondence to: Sun-Mi Choi, OMD, PhD, Department of Medical Research, Korea Institute of Oriental Medicine, 483 Exporo, Yuseong-gu, Daejeon 305-811, South Korea. smchoi@kiom.re.kr
Telephone: +82-42-8689485     
Fax: +82-42-8639464
Received: September 22, 2008
Revised: December 11, 2008
Accepted: December 18, 2008
Published online: February 28, 2009

Abstract

AIM: To investigate the protective effects of electroacupuncture (EA) pretreatment on acetylsalicylic acid (ASA)-induced ulceration in rats.

METHODS: We randomly divided 72 rats into three groups including control (administered with distilled water), ASA group (administered 100 mg/kg ASA) and EA group (administered EA + 100 mg/kg ASA). Each rat was fasted for 18 to 24 h before experimentation, and lesion scores, gastric acidity, cyclooxygenase (COX)-1 and -2 mRNA levels, and total nitric oxide (NO) concentration were measured.

RESULTS: The lesion scores of the EA group were significantly lower than those of the ASA group. Gastric acidity of the ASA and EA groups was reduced compared to the control group. COX-1 and -2 mRNA levels were significantly increased in the EA group as compared to the control and ASA groups, and NO levels were also significantly increased in the EA group as compared to the ASA group.

CONCLUSION: These results suggest that EA-mediated protection against ASA-induced ulceration in rats may occur via gastric defense components.

Key Words: Electroacupuncture; Acute gastritis; Cyclooxygenase; Nitric Oxide



INTRODUCTION

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used as anti-inflammatory and analgesic agents[12]. Unfortunately, they often cause gastrointestinal injury in gastric lesions by inhibiting COX; however, the detailed mechanism remains unclear[3]. Thus, effective strategies are required to protect the gastrointestinal mucosa. Acupuncture has been used to treat a wide variety of conditions, including fever, inflammation, infection and, especially, stomach diseases[45]. Therefore, we have investigated the protective effects of acupuncture against NSAID-induced ulceration in a rat model. Oxidization of arginine by nitric oxide synthase (NOS) creates the volatile gas NO, which has numerous physiologic properties, including regulation of inflammation and a role in gastric mucosal defense[67].

Acupuncture has been used to treat different gastrointestinal disorders in East Asian countries. ST-36 (stomach-36) is the common point for the treatment of gastric symptoms, such as nausea and vomiting, suggesting that acupuncture at ST-36 may stimulate gastrointestinal motility in humans[8]. A previous study has demonstrated that electroacupuncture (EA) at ST-36 inhibits acid secretion in conscious dogs and that naloxone reversed the EA-induced inhibition of acid secretion[9]. Other studies reported that EA stimulation at ST-36 increases gastric acid secretion in rats, and sectioning of the sciatic nerve blocked the acupuncture induced acid secretion[10]. Many studies reported improvement of gastrointestinal symptoms, but the mechanism of the beneficial effects of acupuncture remains to be investigated.

In this study, we investigated whether pretreatment with EA could protect against 100 mg/kg ASA-induced ulceration in rats by regulating acidity, COX mRNA and NO levels of gastric defensive components.

MATERIALS AND METHODS
Animals

Seventy-two adult male Sprague-Dawley rats (Orient Bio Inc., Korea) weighing 170-210 g were included in this study. The rats were randomly divided into three groups: control (fasted 18-24 h and orally administered 1 mL DW), ASA (fasted 18-24 h and orally administered 100 mg/kg ASA) and EA (fasted 18-24 h, treated with EA for 30 min, and then immediately orally administered 100 mg/kg ASA). Rats were housed at 22 ± 1°C and 55% ± 10% humidity on a 12 h light/12 h dark cycle with free access to food and water. All experimental procedures were approved by the Laboratory Animal Center at the Korea Institute of Oriental Medicine. After the rats were allowed to adjust to their new environment for three to four days, they were kept in cages with raised mesh bottoms and deprived of food, but allowed free access to tap water for 18 to 24 h.

Electroacupuncture stimulation

EA was applied via bilateral electrical stimulation at the ST36 acupuncture point using a pair of bipolar stimulation electrodes in rats under 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane (isoflurane) anesthesia. The electrical stimulation condition was biphasic pulses with 10 Hz frequency, 1 mA current and a duration of 0.1 ms.

Lesion score measurement

Like the EA group, the ASA group was anesthetized for 30 min; during this 30-min period, the EA group also received EA at ST-36 for 30 min before receiving 1 mL ASA (100 mg/kg) under isoflorane anesthesia. The control group was anesthetized for 30 min and administered 1 mL DW. Four hours later, all rats were sacrificed under i.p. pentobarbital (50 mg/kg, HANLIM PHARM. CO., Ltd, Korea) anesthesia to score the lesions of each stomach after inflation with 5 mL phosphate-buffered saline (PBS, pH 7.4). We utilized direct scanning of stomach samples to measure the gastric lesions with public domain image processing and analysis software developed at the National Institutes of Health, USA. The PC version of this program (2.15 MB), known as Scion Image, is freely available on the internet from Scion Corporation (http://www.scioncorp.com, Scion Image for Windows, Release Alpha 4.0.3.2)[11].

Determination of gastric acidity

Gastric acidity was measured using the pylorus ligation technique. Briefly, the abdomen was incised, and the pylorus was ligated under isoflurane anesthesia. Rats were continuously anesthetized for 30 min. The EA group received EA at ST36 for 30 min under anesthesia. Afterwards, the control group received distilled water, and the ASA and EA groups received ASA (100 mg/kg). Four hours after completion of all procedures, each group of rats was sacrificed under i.p. pentobarbital (50 mg/kg, HANLIM PHARM. CO., Ltd, Korea) anesthesia, and the gastric juices were collected. Gastric juices were centrifuged at 5500 r/min for 10 min and used for the following measurement. Titratable acidity was determined in a 200 &mgr;L aliquot of the gastric juice supernatant with 0.1 mol/L NaOH using phenol red as an indicator. Results were expressed as &mgr;Eq/200 &mgr;L.

Analysis of COX-1 and COX-2 mRNA by reverse transcription-polymerase chain reaction (RT-PCR)

Stomach samples for RT-PCR were immediately frozen in liquid nitrogen and stored at -70°C until use. Total RNA was extracted from the stomach samples that were pooled from three rats using RNA Bee (Tel-Test Inc., TX, USA) and isopropanol-chloroform extraction. After isolating the RNA, we performed RNA quantitation using a spectrophotometer (NanoDrop ND-1000, NanoDrop, Texas, USA). Total RNA was reverse transcribed using a RevertAidTM First Strand cDNA Synthesis Kit (Asuragen Inc., Texas, USA) according to the manufacturers’ instructions. β-actin levels were constant in all groups. The resulting cDNAs were amplified by PCR using β-actin, COX-1 or COX-2 specific primers, 10 mol/L dNTP, 10X Taq buffer and Taq. PCR cycling conditions consisted of 45 s at 94°C, 45 s at 59.3°C and 1 min for 72°C for β-actin and for 30 s at 94°C, 30 s at 53.6°C and 45 s at 72°C for COX-1 and -2. The sense and antisense primers were 5'-TGT GATGGTGGGAATGGGTCAG-3' and 5'-TTTGAT GTCACGCACGATTTCC-3' for β-actin (514 bp); 5'-GCCTCGACCACTACCAATGT-3' and 5'-AGG TGGCAT TCACAAACTCC-3' for COX-1 (167 bp); and 5'-TAC CCGGACTGGATTCTACG-3' and 5'-AAGTTGGTG GGCTGTCAATC-3' for COX-2 (214 bp). PCR was conducted for 28 cycles for COX-1 and -2, and 30 cycles for β-actin. Amplified DNA was electrophoresed in a 1.5% agarose gel. Fragment size was assessed by comparison to a 100 bp DNA marker (Solgent, Korea).

Determination of NO concentration

The gastric mucosa of each rat was removed by scrubbing and then weighed. NO content was determined using the Nitrate/Nitrite Colorimetric Assay Kit (Cayman Chemical Co, MI, USA). Briefly, samples were homogenized in PBS (pH 7.4), centrifuged at 10 000 r/min for 20 min, and then ultra-filtered using a 30 kDa molecular weight cut-off filter (Millipore Corporation, MA, USA). Nitrate in the prepared samples was converted to nitrite using nitrate reductase and subsequently coupled with N-1-naphthyl-ethylene diamine to give a colored product whose concentration was measured colorimetrically at a wavelength of 540 nm.

Statistical analysis

All data were expressed as mean ± SE using SPSS for windows (version 11, SPSS, Inc., Chicago, USA). Differences between means were analyzed using one-way analysis of variance (ANOVA) with the Tukey post-hoc test for multiple comparisons as well as Student’s t-test, P < 0.05 was considered significant.

RESULTS
EA decreased lesion severity

The lesion scores of the EA group (305.55 ± 29.67 mm2, n = 8) were significantly lower (P < 0.05) than those of the ASA group (402.64 ± 28.25 mm2, n = 8), as shown in Figure 1. Thus, EA pretreatment significantly protected against gastric lesions induced by 100 mg/kg ASA.

Figure 1
Figure 1 Protective effect of pretreatment of EA on ASA-induced gastric lesions in rats. Data are presented as the mean ± SE (n = 8 each group). aP < 0.05 compared with ASA group. ASA: Acetylsalicylic acid (100 mg/kg); EA: Electro-acupuncture.
Effects of EA on acid secretion

Figure 2 shows the gastric acidity for each group: 145.2 ± 19.9 &mgr;Eq/200 &mgr;L for the control group (n = 5), 84.86 ± 11.03 &mgr;Eq/200 &mgr;L for the ASA group (n = 7), and 78.13 ± 8.01 &mgr;Eq/200 &mgr;L for the EA group (n = 8). The gastric acidity of both the ASA and EA groups was significantly lower than that of the control group (P < 0.05 in both groups).

Figure 2
Figure 2 Determination of gastric acidity was measured in terms of each group. Rats were treated with or without 100 mg/kg ASA after anesthesia and pretreatment of EA on ST-36 for 30 min. Data are presented as the mean ± SE. aP < 0.05 compared with Control group. Control: Distilled water (n = 5); ASA: Acetylsalicylic acid (100 mg/kg, n = 7); and EA+ASA: Electro-acupuncture on ST-36 + ASA (n = 8).
COX-1 and COX-2 levels

The level of COX-1 mRNA in the ASA group was significantly decreased at one and two hours after administration of 100 mg/kg ASA (Figure 3 columns B and C) and then increased at four hours after administration (Figure 3 column D) compared to the control group (column A). Expression of COX-1 mRNA in the EA group was significantly increased at one, two and four hours after administration of 100 mg/kg ASA (Figure 3, columns E, F, G) compared to the control group. COX-2 mRNA levels were slightly up-regulated in all tested conditions and time points, except for the strong up-regulation observed in the EA group at four hours after administration of 100 mg/kg ASA (Figure 3).

Figure 3
Figure 3 Expression of COX-1, 2 mRNAs in the rat stomach after oral administration of DW, ASA (100 mg/kg) or ASA (10 mg/kg) with EA pretreatment (n = 3 each group). A: Control; B: one hour after administration of ASA (100 mg/kg); C: Two hours after administration of ASA (100 mg/kg); D: Four hours after administration of ASA (100 mg/kg); E: One hour after administration of ASA (100 mg/kg) with EA pretreatment; F: Two hours after administration of ASA (100 mg/kg) with EA pretreatment; G: Four hours after administration of ASA (100 mg/kg) with EA pretreatment. ASA: Acetylsalicylic acid; EA: Electroacupuncture.
Determination of NO concentration

The total nitrate (NO3-) and nitrite (NO2-) concentrations of control, ASA and EA groups were 44.48 ± 2.06 &mgr;mol/L, 19.34 ± 1.05 &mgr;mol/L and 32.96 ± 1.68 &mgr;mol/L, respectively (Figure 4). These results demonstrate that the total NO in the EA group was significantly higher than that of the ASA group, but still significantly lower than that of the control group.

Figure 4
Figure 4 Total nitric oxide (NO) concentration of each group. Values are each a mean ± SE (n = 5 each group). aP < 0.05 compared with Control; cP < 0.05 compared with ASA group. Control: Distilled water, ASA: Acetylsalicylic acid (100 mg/kg); EA: Electro-acupuncture.
DISCUSSION

Acupuncture has been used to treat stomach diseases with few adverse effects. In this study, we found that the lesions scores of the EA group were significantly lower than in the ASA group. Although hypotheses abound regarding NSAID-induced gastric damage, the exact mechanism remains unclear.

The acidity of gastric secretions is important for modulating gastric defenses because acid can interfere with restitution, resulting in the conversion of superficial injury to deeper mucosal necrosis[12]. Additionally, because several growth factors (e.g. fibroblast growth factor) that are important for maintenance of mucosal integrity and repair of superficial injury are acid-labile, the presence of acid in the lumen can limit the contributions of these factors to mucosal defense and repair[13]. Decreased acidity in the ASA and EA groups in the present study might have resulted from compensation for the destruction of gastric defense mechanisms by exposure to 100 mg/kg ASA.

The expression of COX-1 mRNA was increased in the EA group, but decreased in the ASA group. The expression of COX-2 mRNA in the EA groups gradually increased over time. This study thus showed that both COX-1 and COX-2 are inducible, which contradicts previous studies[14]. The reduction of gastric blood flow following NSAID administration appears to primarily arise from COX-1 inhibition, but neutrophil adherence following NSAID administration appears to be due to COX-2 suppression[12]. Administration of a selective COX-2 inhibitor, but not a COX-1 inhibitor, has been shown to induce neutrophil adherence[15]. A previous study reported that treatment with a selective COX-2 inhibitor aggravated dextran sulfate sodium-induced inflammation in the colon and that endogenous prostaglandins (PGs) were involved in the mucosal defense against chemo-induced ulceration; this response was produced by COX-1 in the early phase and COX-2 in the late phase[16]. Thus, the presently observed inducible expression of COX-1 in the early phase and COX-2 in the late phase suggests that EA pretreatment might up-regulate the mucosal defense mechanism.

NO in the vascular endothelium mediates various biological actions under physiological conditions[17] and also plays an important role in the modulation of gastric mucosal integrity by interacting with other protective mediators[1819]. Several studies have reported that NO, or NO donors, stimulate PG production in various organs and cells[2022] and up-regulate acid-induced HCO3- secretion[23]. The total NO concentration in the EA group was significantly increased with respect to that of the ASA group. This increase of total NO likely protected the gastric mucosa against ASA-induced toxicity. Furthermore, EA-induced NO induction may in turn increase production of PG and HCO3-.

In conclusion, EA pretreatment might be effective for gastric defense against ASA-induced ulceration.

COMMENTS
Background

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used as anti-inflammatory and analgesic agents though they often cause gastrointestinal injury in gastric lesions by inhibiting COX. Thus, effective strategies are required to protect the gastrointestinal mucosa.

Research frontiers

In this study, the authors demonstrate that the time-dependent expression of COX could be a potential mechanism for mediating the beneficial effects of acupuncture. The PGs-related acupuncture mechanism should be undertaken, because the endogenous prostaglandins (PGs) are involved in the mucosal defense against chemo-induced ulceration.

Innovations and breakthroughs

The inducible expression of COX-1 in the early phase and COX-2 in the late phase suggests that EA pretreatment might up-regulate the mucosal defense mechanism. The total NO concentration in the EA group was significantly increased with respect to that of the ASA group. The total NO likely protected the gastric mucosa against ASA-induced toxicity. The EA pretreatment might be effective for gastric defense against ASA-induced ulceration.

Application

By understanding the time-dependent expression of COX by EA pretreatment, this study may represent a future strategy for therapeutic intervention in the treatment of patients with gastritis by Nonsteroidal anti-inflammatory drugs.

Terminology

Acupuncture is a technique of inserting and manipulating fine filiform needles into specific points on the body with the aim of relieving pain and for therapeutic purposes. According to traditional Chinese medical theory, these acupuncture points lie along meridians along which qi, the vital energy, flows.

Peer review

The methodology employed is sound and reproducible. The scientific and innovative contents of this manuscript can reflect the advanced levels of the clinical and basic researches in gastroenterology both at home and abroad.

Footnotes

Supported by Acupuncture, Moxibustion and Meridian Research Project, K08010

References
1.  Hall J, Morand EF, Medbak S, Zaman M, Perry L, Goulding NJ, Maddison PJ, O'Hare JP. Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Effects of nonsteroidal antiinflammatory drugs and water immersion. Arthritis Rheum. 1994;37:1132-1137.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Rashad S, Revell P, Hemingway A, Low F, Rainsford K, Walker F. Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet. 1989;2:519-522.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Andrews FJ, Malcontenti-Wilson C, O'Brien PE. Effect of nonsteroidal anti-inflammatory drugs on LFA-1 and ICAM-1 expression in gastric mucosa. Am J Physiol. 1994;266:G657-G664.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Pei WF, Xu GS, Sun Y, Zhu SL, Zhang DQ. Protective effect of electroacupuncture and moxibustion on gastric mucosal damage and its relation with nitric oxide in rats. World J Gastroenterol. 2000;6:424-427.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Yan J, Yang RD, He JF, Yi SX, Chang XR, Lin YP. Effect of acupuncture at different meridian acupoints on changes of related factors for rabbit gastric mucosal injury. World J Gastroenterol. 2005;11:6472-6476.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Wallace JL, Miller MJ. Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology. 2000;119:512-520.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Konturek SJ, Brzozowski T, Majka J, Pytko-Polonczyk J, Stachura J. Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. Eur J Pharmacol. 1993;239:215-217.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Takahashi T. Acupuncture for functional gastrointestinal disorders. J Gastroenterol. 2006;41:408-417.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Jin HO, Zhou L, Lee KY, Chang TM, Chey WY. Inhibition of acid secretion by electrical acupuncture is mediated via beta-endorphin and somatostatin. Am J Physiol. 1996;271:G524-G530.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Noguchi E, Hayashi H. Increases in gastric acidity in response to electroacupuncture stimulation of the hindlimb of anesthetized rats. Jpn J Physiol. 1996;46:53-58.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Khan HA. Computer-assisted visualization and quantitation of experimental gastric lesions in rats. J Pharmacol Toxicol Methods. 2004;49:89-95.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Wallace JL. Pathogenesis of NSAID-induced gastroduodenal mucosal injury. Best Pract Res Clin Gastroenterol. 2001;15:691-703.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Szabo S, Folkman J, Vattay P, Morales RE, Pinkus GS, Kato K. Accelerated healing of duodenal ulcers by oral administration of a mutein of basic fibroblast growth factor in rats. Gastroenterology. 1994;106:1106-1111.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Bhandari P, Bateman AC, Mehta RL, Patel P. Mucosal expression of cyclooxygenase isoforms 1 and 2 is increased with worsening damage to the gastric mucosa. Histopathology. 2005;46:280-286.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Wallace JL, McKnight W, Reuter BK, Vergnolle N. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology. 2000;119:706-714.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Park YS. [COX-2 inhibitors in inflammatory bowel disease: friends or foes?]. Korean J Gastroenterol. 2007;50:350-355.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Pique JM, Whittle BJ, Esplugues JV. The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation. Eur J Pharmacol. 1989;174:293-296.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Whittle BJ, Lopez-Belmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol. 1990;99:607-611.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Furukawa O, Kitamura M, Sugamoto S, Takeuchi K. Stimulatory effect of nitric oxide on bicarbonate secretion in bullfrog duodenums in vitro. Digestion. 1999;60:324-331.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Uno H, Arakawa T, Fukuda T, Yu H, Fujiwara Y, Higuchi K, Inoue M, Kobayashi K. Nitric oxide stimulates prostaglandin synthesis in cultured rabbit gastric cells. Prostaglandins. 1997;53:153-162.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Watkins DN, Garlepp MJ, Thompson PJ. Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide. Br J Pharmacol. 1997;121:1482-1488.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Aihara E, Sasaki Y, Ise F, Kita K, Nomura Y, Takeuchi K. Distinct mechanisms of acid-induced HCO3- secretion in normal and slightly permeable stomachs. Am J Physiol Gastrointest Liver Physiol. 2006;291:G464-G471.  [PubMed]  [DOI]  [Cited in This Article: ]